financetom
Business
financetom
/
Business
/
Uber Faces $125 Million DOJ Lawsuit Over Alleged Disability Discrimination
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Uber Faces $125 Million DOJ Lawsuit Over Alleged Disability Discrimination
Sep 12, 2025 11:38 AM

02:06 PM EDT, 09/12/2025 (MT Newswires) -- Uber Technologies ( UBER ) is being sued by the US Department of Justice for allegedly discriminating against passengers with disabilities, including people who use service animals and mobility devices like stowable wheelchairs, the DOJ said Friday.

The lawsuit, filed Thursday in the US District Court for the Northern District of California, seeks $125 million in damages for individuals who previously filed complaints with either Uber ( UBER ) or the DOJ, it added.

The complaint alleges that Uber ( UBER ) and its drivers frequently refuse to provide rides to individuals with disabilities, impose impermissible fees, such as cleaning charges for service animal shedding or cancellation fees for denied rides, and fail to make policy changes that discourage such discrimination.

The DOJ said it is also asking the court to require Uber ( UBER ) to change its policies to comply with the Americans with Disabilities Act, train its employees and drivers on the law, and stop all discriminatory practices. The lawsuit also seeks a civil penalty to "vindicate the public's interest in eliminating disability discrimination."

"We have a clear zero-tolerance policy for confirmed service denials, and we fundamentally disagree with the DOJ's allegations," the company told MT Newswires.

Uber ( UBER ) added that it requires all drivers to agree to its US Service Animal Policy and follow accessibility laws before they can use the Driver app, and that the company also regularly reminds drivers of these rules. "When we confirm a violation, we take decisive action, including permanent account deactivation."

Price: 95.39, Change: +0.70, Percent Change: +0.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved